Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women

NCT02877979 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV

Interventions

DRUG: DS003 vaginal tablet
DRUG: Placebo

Sponsor

International Partnership for Microbicides, Inc.